Oxytocin differently regulates pressor responses to stress in WKY and SHR rats: The role of central oxytocin and V1a receptors

Stress

Volumn 17, Issue 1, 2014, Pages 117-125

  Wsol, A ^a   Szczepanska Sadowska, E ^a   Kowalewski, S ^a   Puchalska, L ^a   Cudnoch Jedrzejewska, A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Air jet stress; Blood pressure; Hypertension; Neuropeptides; Oxytocin antagonist; Vasopressin antagonist

Indexed keywords

OXYTOCIN; OXYTOCIN RECEPTOR; VASOPRESSIN V1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRESS; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; HEART RATE; MALE; OXYTOCIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; REST; STRESS, PSYCHOLOGICAL;

EID: 84890960813     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2013.872620     Document Type: Article

References (48)

1. Akerlund M, Bossmar T, Brouard R, Kostrzewska A, Laudanski T, Lemancewicz A, Serradeil-Le Gal C, Steinwall M. (1999). Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women. Br J Obst Gynaecol 106:1047-53.
2. Alizadeh AM, Mirzabeglo P. (2013). Is oxytocin a therapeutic factor for ischemic heart disease? Peptides 45:66-72.
3. Authier S, Tanguay JF, Geoffroy P, Gauvin D, Bichot S, Ybarra N, Otis C, Troncy E. (2010). Cardiovascular effects of oxytocin infusion in a porcine model of myocardial infarct. J Cardiovasc Pharmacol 55: 74-82.
4. Bao AM, Meynen G, Swaab DF. (2008). The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 57:531-53.
5. Barberis C, Mouillac B, Durroux T. (1998). Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 156:223-9.
6. Barberis C, Tribollet E. (1996). Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurobiol 10:119-54.
7. Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M, Neumannn ID. (2008). Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 27:1947-56.
8. Boccia ML, Petrusz P, Suzuki K, Marson L, Pedersen CA. (2013). Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience 253C:155-64.
9. Cudnoch-Jedrzejewska A, Dobruch J, Puchalska L, Szczepanska- Sadowska E. (2007). Interaction of AT1 receptors and V1a-receptors mediated effects in the central cardiovascular control during the postinfarct state. Regul Pept 142:86-94.
10. Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E, Dobruch J, Gomolka R, Puchalska L. (2010). Brain vasopressin V1 receptors contribute to enhanced cardiovascular responses to acute stress in chronically stressed rats and rats with myocardial infarction. Am J Physiol Regul Integr Comp Physiol 298:R672-80.
11. Curran-Everett D, Benos DJ. (2004). Guidelines for reporting statistics in journals published by the American Physiological Society. Physiol Genomics 18:249-51.
12. Dobruch J, Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E. (2005). Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction. Stress 8:273-84.
13. Engelmann M, Ebner K, Landgraf R, Hoisboer F, Wojtak CT. (1999). Emotional stress triggers intrahypothalmic but not peripheral release of oxytocin in male rats. Neuroendocrinology 11:867-72.
14. Feuerstein G, Zerbe RL, Faden AI. (1984). Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. J Pharmacol Exp Ther 228:348-53.
15. Gaida W, Lang RE, Kraft K, Unger T, Ganten D. (1985). Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence? Clin Sci 68:35-43.
16. Gimpl G, Fahrenholz F. (2001). The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629-83.
17. Gimpl G, Reitz J, Brauer S, Trossen C. (2008). Oxytocin receptors: ligand binding, signalling and cholesterol dependence. Prog Brain Res 170:193-204.
18. Grippo AJ, Cushing BS, Carter CS. (2007). Depression-like behavior and stressor-induced neuroendocrine activation in female prairie voles exposed to chronic social isolation. Psychosom Med 69:149-57.
19. Gozdz A, Szczepan'ska-Sadowska E, Mas'lin'ski W, Kumosa M, Szczepan'ska K, Dobruch J. (2003). Differential expression of vasopressin V1a and V1b receptors mRNA in the brain of renin transgenic TGR(mRen2)27 and Sprague-Dawley rats. Brain Res Bull 59:399-403.
20. Gutkowska J, Jankowski M. (2012). Oxytocin re-visited. Its role in cardiovascular regulation. J Neuroendocrinol 24:599-608.
21. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM. (1997). Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 94:11704-9.
22. Hernando F, Schoots O, Lolait SJ, Burbach JP. (2001). Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 142: 1659-68.
23. Krieger EM, Brum PC, Negra?o CE. (1999). Influence of exercise training on neurogenic control of blood pressure in spontaneously hypertensive rats. Hypertension 34:720-3.
24. Lee HJ, Macbeth AH, Pagani JH, Young 3rd WS. (2009). Oxytocin: the great facilitator of life. Prog Neurobiol 88:127-151.
25. Ludbrook J. (1994). Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303-11.
26. Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, Durroux T, et al. (2012). Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol 24:609-28.
27. Manning M, Miteva K, Pancheva S, Stoyev S, Wo NC, Chan WY. (1995). Design and synthesis of highly selective in vitro and in vivo uterine receptors antagonists of oxytocin: comparisons with Atosiban. Int J Peptide Protein Res 46:244-52.
28. Martins AS, Crescenzi A, Stern JE, Bordin S, Michelini LC. (2005). Hypertension and exercise training differentially affect oxytocin and oxytocin receptor expression in the brain. Hypertension 46:1004-9.
29. Mezzacappa ES, Kelsey RM, Myers MM, Katkin ES. (2001). Breastfeeding and maternal cardiovascular function. Psychophysiology 38: 988-97.
30. Mezzacappa ES, Tu AY, Myers MM. (2003). Lactation and weaning effects on physiological and behavioral response to stressors. Physiol Behav 78:1-9.
31. Neumann I, Douglas AJ, Pittman QJ, Russell JA, Landgraf R. (1996). Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events. J Neuroendocrinol 8:227-33.
32. Neumann ID, Landgraf R. (2012). Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 35:649-59.
33. Nishioka T, Anselmo-Franci JA, Callahan MF, Morris M. (1998). Stress increases oxytocin release within hypothalamic paraventricular nucleus. Brain Res 781:56-60.
34. Petersson M, Alster P, Lundeburg T, Uvna?s-Moberg K. (1996). Oxytocin causes a long time decrease of blood pressure in female and male rats. Physiol Behav 60:1311-15.
35. Petersson M, Diaz-Cabiale Z, Angel Narva'ez J, Fuxe K, Uvna?s-Moberg K. (2005). Oxytocin increases the density of high affinity alpha(2)- adrenoceptors within the hypothalamus, the amygdala and the nucleus of the solitary tract in ovariectomized rats. Brain Res 1049:234-9.
36. Petersson M, Lundeberg T, Uvna?s-Moberg K. (1999). Oxytocin enhances the effects of clonidine on blood pressure and locomotor activity in rats. J Auton Nerv Syst 78:49-56.
37. Petersson M, Uvna?s-Moberg K. (2007). Effects of acute stressor on blood pressure and heart rate in rats pretreated with intracerebroventricular oxytocin injections. Psychoneuroendocrinology 32:959-65.
38. Schafer EA, Mackenzie K. (1911). The action of animal extracts on milk secretion. Proc R Soc Lon B 84:16-22.
39. Serradeil-Le Gal C, Wagnon J, Garcia C, Lacour C, Guiraudou P, Christophe B, Villanova G, et al. (1993). Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. J Clin Invest 92:224-31.
40. Sofroniew MV. (1985). Vasopressin- and neurophysin-immunoreactive neurons in the septal region, medial amygdala and locus coeruleus in colchicine-treated rats. Neuroscience 15:347-58.
41. van Tol HH, van den Buuse M, de Jong W, Burbach JP. (1988). Vasopressin and oxytocin gene expression in the supraoptic and paraventricular nucleus of the spontaneously hypertensive rat (SHR) during development of hypertension. Brain Res 464:303-11.
42. Versteeg CA, Cransberg K, De Jong W, Bohus B. (1983). Reduction of centrally induced pressor response by neurohypophyseal peptides: the involvement of lower brainstem mechanisms. Eur J Pharmacol 94: 133-40.
43. Viviani D, Stoop R. (2008). Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog Brain Res 170: 207-18.
44. Windle RJ, Gamble LE, Kershaw YM, Wood SA, Lightman SL, Ingram CD. (2006). Gonadal steroid modulation of stress-induced hypothalamo- pituitary-adrenal activity and anxiety behavior: role of central oxytocin. Endocrinology 147:2423-31.
45. Windle RJ, Shanks N, Lightman SL, Ingam CD. (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138:2829-34.
46. Wsol A, Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E, Kowalewski S, Dobruch J. (2009). Central oxytocin modulation of acute stress-induced cardiovascular responses after myocardial infarction in the rat. Stress 12:517-25.
47. Zhang W, Huang BS, Leenen FHH. (1999). Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 276:H1608-15.
48. Zingg HH, Laporte SA. (2003). The oxytocin receptor. Trends Endocrinol Metab 14:222-7.